Neuropace Inc
NASDAQ:NPCE
Neuropace Inc
Cash from Investing Activities
Neuropace Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neuropace Inc
NASDAQ:NPCE
|
Cash from Investing Activities
$23m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-114%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Neuropace Inc's Cash from Investing Activities?
Cash from Investing Activities
23m
USD
Based on the financial report for Dec 31, 2023, Neuropace Inc's Cash from Investing Activities amounts to 23m USD.
What is Neuropace Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
-3%
Over the last year, the Cash from Investing Activities growth was -3%.